Open access
1,039
Views
0
CrossRef citations to date
0
Altmetric
Supplement: introducing oral semaglutide and the PIONEER program to primary care
Introducing a novel therapy for type 2 diabetes to primary care
Stephen A. BruntonTouro University California, Vallejo, CA, USACorrespondence[email protected]
View further author information
View further author information
Pages 1-2
|
Received 17 Jul 2020, Accepted 17 Jul 2020, Published online: 08 Sep 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.